Director hire for corporate healthcare trust provider
Corporate healthcare trust provider Healix Health has hired an ex-AXA head of global distribution to drive further growth in the business.
Luke Harding, who joins as commercial director, comes with almost 20 years’ experience in the corporate healthcare and employee benefits space. He previously held positions at Mercer as a senior associate, and most recently at Axa Global Healthcare where he was responsible for designing, running and launching corporate distribution.
This included developing Axa’s global healthcare corporate business in the Middle East and Asia, as well as their established markets in the UK and Europe.
His role will focus on driving the business forward in the direct and broker markets, with his remit focusing on developing broker strategies and strengthening broker relationships. He will also be responsible for expanding distribution channels to help bolster Healix Health’s client portfolio. His remit will also involve supporting its existing clients to scale up their healthcare provision.
The hire comes as Bristol-based Healix Health has seen its revenue increase by over 140% since 2020, with a 67% simultaneous increase in the amount of people supported via workplace schemes.
[AuthorRecommendedPosts]The news also comes following a string of recent partnerships which have supported Healix’s member organisations to widen their remit of support offered to employees.
This includes a recent partnership with Check4Cancer, to offer faster access to cancer treatment, and with Syrona to enable members to access virtual consultations with specialist clinicians across a range of health concerns including menopause, endometriosis and fertility.
Ian Talbot, CEO of Healix Health, said: “We are thrilled to welcome Luke to the team, who brings a wealth of experience in the sector. The employee benefits market is only set to grow and expand as people increasingly look to their employers to plug the gaps in existing healthcare provision. Luke will be integral for the next stage of growth for Healix.”
